These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21775980)

  • 1. Impaired formation of stimulus-response, but not action-outcome, associations in rats with methamphetamine-induced neurotoxicity.
    Son JH; Latimer C; Keefe KA
    Neuropsychopharmacology; 2011 Nov; 36(12):2441-51. PubMed ID: 21775980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.
    Howard CD; Daberkow DP; Ramsson ES; Keefe KA; Garris PA
    Eur J Neurosci; 2013 Jul; 38(1):2078-88. PubMed ID: 23574406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in neural circuitry regulating response-reversal learning and Arc-mediated consolidation of learning in rats with methamphetamine-induced partial monoamine loss.
    Pastuzyn ED; Keefe KA
    Neuropsychopharmacology; 2014 Mar; 39(4):963-72. PubMed ID: 24150570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methamphetamine neurotoxicity on learning-induced Arc mRNA expression in identified striatal efferent neurons.
    Daberkow DP; Riedy MD; Kesner RP; Keefe KA
    Neurotox Res; 2008 Dec; 14(4):307-15. PubMed ID: 19073434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity.
    Friend DM; Son JH; Keefe KA; Fricks-Gleason AN
    J Pharmacol Exp Ther; 2013 Feb; 344(2):511-21. PubMed ID: 23230214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.
    Robinson JD; Howard CD; Pastuzyn ED; Byers DL; Keefe KA; Garris PA
    Neurotox Res; 2014 Aug; 26(2):152-67. PubMed ID: 24562969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methamphetamine-induced neurotoxicity on striatal long-term potentiation.
    Gibson AS; West PJ; Keefe KA
    Psychopharmacology (Berl); 2022 Jan; 239(1):93-104. PubMed ID: 34985532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered learning and Arc-regulated consolidation of learning in striatum by methamphetamine-induced neurotoxicity.
    Pastuzyn ED; Chapman DE; Wilcox KS; Keefe KA
    Neuropsychopharmacology; 2012 Mar; 37(4):885-95. PubMed ID: 22071872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.
    Quinton MS; Yamamoto BK
    Psychopharmacology (Berl); 2007 Aug; 193(3):341-50. PubMed ID: 17458543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine sensitization by methamphetamine treatment prior to instrumental training delays the transition into habit in female rats.
    Schoenberg HL; Evans C; Bausch L; Wootton A; Kirshenbaum A; Toufexis DJ
    Behav Brain Res; 2022 Feb; 418():113636. PubMed ID: 34687828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum.
    Stephans SE; Whittingham TS; Douglas AJ; Lust WD; Yamamoto BK
    J Neurochem; 1998 Aug; 71(2):613-21. PubMed ID: 9681451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perseverative behavior in rats with methamphetamine-induced neurotoxicity.
    Son JH; Kuhn J; Keefe KA
    Neuropharmacology; 2013 Apr; 67():95-103. PubMed ID: 23159331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation.
    Faure A; Haberland U; Condé F; El Massioui N
    J Neurosci; 2005 Mar; 25(11):2771-80. PubMed ID: 15772337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.
    Howard CD; Keefe KA; Garris PA; Daberkow DP
    J Neurochem; 2011 Aug; 118(4):668-76. PubMed ID: 21668447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
    Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity.
    Stephans S; Yamamoto B
    Neuroscience; 1996 Jun; 72(3):593-600. PubMed ID: 8861054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of methamphetamine on the production of free radicals and oxidative stress.
    Yamamoto BK; Zhu W
    J Pharmacol Exp Ther; 1998 Oct; 287(1):107-14. PubMed ID: 9765328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine.
    Barker-Haliski ML; Oldenburger K; Keefe KA
    J Neurochem; 2012 Dec; 123(5):845-55. PubMed ID: 22978492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.